Birzeit Pharmaceuticals Company (PEX:BPC)

PEX:BPC Revenue

Birzeit Pharmaceuticals Company had revenue of $12.26M USD in the quarter ending June 30, 2025, with 46.69% growth. This brings the company's revenue in the last twelve months to $45.71M, up 15.68% year-over-year. In the year 2024, Birzeit Pharmaceuticals Company had annual revenue of $40.65M, down -5.74%.

• Revenue (ttm): $45.71M
• Revenue Growth: +15.68%
• P/S Ratio: 3.10
• Revenue / Employee: $152.35K
• Employees: 300
• Market Cap: 100.30M JOD

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	40.65M	-2.48M	-5.74%
Dec 31, 2023	43.13M	-3.91M	-8.31%
Dec 31, 2022	47.03M	1.56M	3.44%
Dec 31, 2021	45.47M	9.62M	26.82%
Dec 31, 2020	35.85M	1.28M	3.70%